The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 39, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-23
DOI
10.1007/s12032-022-01688-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel treatments for anaplastic thyroid carcinoma
- (2020) Silvia Martina Ferrari et al. Gland Surgery
- Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors
- (2020) Maria E. Cabanillas et al. THYROID
- Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
- (2019) Dongdong Wu et al. Cancer Cell International
- The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
- (2019) Soojeong Chang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Inhibitory Effect of (−)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing SCUBE2 Methylation and DNMT Activity
- (2019) Jie Sheng et al. MOLECULES
- Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy
- (2018) Kun Liang et al. ADVANCED MATERIALS
- Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model
- (2018) Cristiane Okuda Torello et al. CANCER LETTERS
- SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development
- (2018) Garam Kim et al. FASEB JOURNAL
- Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
- (2018) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
- (2018) Wanchun Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Novel targeted therapies and immunotherapy for advanced thyroid cancers
- (2018) George E. Naoum et al. Molecular Cancer
- S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib
- (2018) Xuelong Jiao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
- (2018) Viswanath Gunda et al. BRITISH JOURNAL OF CANCER
- Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
- (2018) Aide Negri et al. Nutrients
- Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma
- (2018) Mu Liu et al. PeerJ
- Effects of nutraceuticals on anaplastic thyroid cancer cells
- (2017) Lorenzo Allegri et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
- (2017) Naiyarat Prasongsook et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival
- (2016) Scott M. Glaser et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Identification of Novel Oncogenic Mutations in Thyroid Cancer
- (2016) Susan C. Pitt et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Biologic and Clinical Perspectives on Thyroid Cancer
- (2016) James A. Fagin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review
- (2016) Zhiying Huang et al. PHARMACOLOGICAL RESEARCH
- The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells
- (2016) Yi Zhou et al. TUMOR BIOLOGY
- AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer
- (2016) Xi Liu et al. Oncotarget
- Coronin 2A (CRN5) expression is associated with colorectal adenoma-adenocarcinoma sequence and oncogenic signalling
- (2015) Raphael H. Rastetter et al. BMC CANCER
- The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
- (2015) Christian Mayr et al. BMC Complementary and Alternative Medicine
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Aurora kinase A in gastrointestinal cancers: time to target
- (2015) Ahmed Katsha et al. Molecular Cancer
- Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
- (2015) Maria Patrizia Mongiardi et al. Scientific Reports
- Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines
- (2014) E. Baldini et al. ENDOCRINE-RELATED CANCER
- Proteome identification of proteins interacting with histone methyltransferase SET8
- (2013) Yi Qin et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity
- (2013) Katherine C. Soe et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- TGF-β1-induced epithelial–mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in Human A549 lung cancer cells
- (2013) Hyeonseok Ko et al. CANCER LETTERS
- Overexpression of PRMT5 Promotes Tumor Cell Growth and Is Associated with Poor Disease Prognosis in Epithelial Ovarian Cancer
- (2013) Xiangxiang Bao et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27Kip1
- (2013) Courtney Nicholas et al. PLoS One
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- New treatment modalities in advanced thyroid cancer
- (2011) E. Kapiteijn et al. ANNALS OF ONCOLOGY
- Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases
- (2011) V. S. Thakur et al. CARCINOGENESIS
- (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
- (2011) V. Nandakumar et al. CARCINOGENESIS
- Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex
- (2011) Young Chang Lim et al. JOURNAL OF SURGICAL ONCOLOGY
- Epigenetic Control of Estrogen Receptor Expression and Tumor Suppressor Genes Is Modulated by Bioactive Food Compounds
- (2010) Carolin Berner et al. ANNALS OF NUTRITION AND METABOLISM
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now